SCHEMBL19685880

SCHEMBL19685880

Cc1cn(-c2ccccc2)c(=O)c2ccc(N3c4ccc(F)cc4-c4ccccc4Oc4ccccc4-c4cc(F)ccc43)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.38
KDM4E B2RXH2 4/20 0.38
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
DHODH Q02127 1/20 0.35
ESR1 P03372 1/20 0.34
ESRRA P11474 1/20 0.34
ESR2 Q92731 1/20 0.34
TDO2 P48775 4/20 0.33
IDO2 Q6ZQW0 4/20 0.33
IDO1 P14902 3/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
MITF O75030 1/20 0.33
HSP90AA1 P07900 1/20 0.33
RAB9A P51151 1/20 0.33
TP53 P04637 1/20 0.33
RECQL P46063 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
G6PD P11413 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685928 0.90 ESR1 (0.35) LMNAKDM4EMEN1KMT2AESR1
SCHEMBL19685930 0.90 ESR1 (0.38) LMNAKDM4EMEN1KMT2ADHODH
SCHEMBL19686088 0.88 BRD4 (0.38) LMNAKDM4ETDO2IDO2IDO1
SCHEMBL19685877 0.85 MAPK8 (0.37) LMNAMEN1KMT2ATDO2IDO2
SCHEMBL19685879 0.84 LMNA (0.36) LMNAKDM4EMEN1KMT2ADHODH
SCHEMBL19685831 0.80 LMNA (0.34) LMNAKDM4EMEN1KMT2ADHODH
SCHEMBL19686086 0.78 BRD4 (0.40) LMNAMEN1KMT2ATDO2IDO2
SCHEMBL19685968 0.77 ATM (0.36) LMNAKDM4EMEN1KMT2ATDO2
SCHEMBL19686085 0.77 BRD4 (0.43) MEN1KMT2ANR1H2NR1H3
SCHEMBL19685934 0.77 ESR1 (0.34) LMNAKDM4EDHODHESR1ESRRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS LMNA 3026/4885KDM4E 1138/4885MEN1 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.